# Temozolomide in Elderly Patients With KPS < 70

> **NCT01242566** · PHASE2 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 70 (actual)

## Conditions studied

- Primary Brain Tumor
- Glioblastoma

## Interventions

- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT01242566
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-07
- **Primary completion:** 2010-05
- **Final completion:** 2010-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2010-11-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01242566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01242566, "Temozolomide in Elderly Patients With KPS < 70". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01242566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*